Efficacy of the Diabeloop closed-loop system to improve glycaemic control in patients with type 1 diabetes exposed to gastronomic dinners or to sustained physical exercise

被引:26
作者
Hanaire, Helene [1 ]
Franc, Sylvia [2 ,3 ]
Borot, Sophie [4 ]
Penfornis, Alfred [2 ,3 ,5 ]
Benhamou, Pierre-Yves [6 ]
Schaepelynck, Pauline [7 ]
Renard, Eric [8 ,9 ]
Guerci, Bruno [10 ]
Jeandidier, Nathalie [11 ]
Simon, Chantal [12 ]
Hannaert, Patrick [13 ]
Xhaard, Ilham [14 ]
Doron, Maeva [15 ,16 ]
Huneker, Erik [17 ]
Charpentier, Guillaume [2 ,3 ]
Reznik, Yves [18 ]
机构
[1] Univ Toulouse, CHU Toulouse, Dept Diabetol Metab Dis & Nutr, Toulouse, France
[2] Sud Francilien Hosp, Dept Diabet, Corbeil Essonnes, France
[3] Ctr Etud & Rech Intensificat Traitement Diabete, Evry, France
[4] Ctr Hosp Univ Jean Minjoz, Dept Endocrinol Metab Diabet & Nutr, Besancon, France
[5] Univ Paris Sud, Orsay, France
[6] Univ Hosp, Pole DigiDune, Dept Diabetol, Grenoble, France
[7] St Marguerite Hosp, Marseille Univ Hosp, Dept Nutr Endocrinol Metabol Disorders, Marseille, France
[8] Univ Montpellier, Montpellier Univ Hosp, Dept Endocrinol Diabet & Nutr, Montpellier, France
[9] Univ Montpellier, INSERM, CNRS, Inst Funct Genom, Montpellier, France
[10] Univ Lorraine, Endocrinol Diabet Care Unit, Vandoeuvre Les Nancy, France
[11] CHU Strasbourg, Dept Endocrinol Diabet & Nutr, Strasbourg, France
[12] Ctr Hosp Lyon Sud, Dept Endocrinol Diabet & Nutr, Lyon, France
[13] INSERM UMR 1082, IRTOMIT, Sch Med & Pharm Poitiers, Poitiers, France
[14] Ctr Etud & Rech Intensificat Traitement Diabete, Evry, France
[15] Univ Grenoble Alpes, Grenoble, France
[16] CEA LETI MlNATEC Campus, Grenoble, France
[17] 5DIABELOOP SA, Paris, France
[18] Univ Caen, Dept Endocrinol, Cote Nacre Reg Hosp Ctr, Caen, France
关键词
clinical trial; continuous glucose monitoring (CGM); glycaemic control; hypoglycaemia; insulin pump therapy; randomized trial; type; 1; diabetes; MODEL-PREDICTIVE CONTROL; INSULIN DELIVERY; ARTIFICIAL PANCREAS; BLOOD-GLUCOSE; ADOLESCENTS; ADULTS; THERAPY; MULTICENTER; VARIABILITY; RETINOPATHY;
D O I
10.1111/dom.13898
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To compare closed-loop (CL) and open-loop (OL) systems for glycaemic control in patients with type 1 diabetes (T1D) exposed to real-life challenging situations (gastronomic dinners or sustained physical exercise). Methods Thirty-eight adult patients with T1D were included in a three-armed randomized pilot trial (Diabeloop WP6.2 trial) comparing glucose control using a CL system with use of an OL device during two crossover 72-hour periods in one of the three following situations: large (gastronomic) dinners; sustained and repeated bouts of physical exercise (with uncontrolled food intake); or control (rest conditions). Outcomes included time in spent in the glucose ranges of 4.4-7.8 mmol/L and 3.9-10.0 mmol/L, and time in hypo- and hyperglycaemia. Results Time spent overnight in the tight range of 4.4 to 7.8 mmol/L was longer with CL (mean values: 63.2% vs 40.9% with OL; P <= .0001). Time spent during the day in the range of 3.9 to 10.0 mmol/L was also longer with CL (79.4% vs 64.1% with OL; P <= .0001). Participants using the CL system spent less time during the day with hyperglycaemic excursions (glucose >10.0 mmol/L) compared to those using an OL system (17.9% vs 31.9%; P <= .0001), and the proportions of time spent during the day with hyperglycaemic excursions of those using the CL system in the gastronomic dinner and physical exercise subgroups were of similar magnitude to those in the control subgroup (18.1 +/- 6.3%, 17.2 +/- 8.1% and 18.4 +/- 12.5%, respectively). Finally, times spent in hypoglycaemia were short and not significantly different among the groups. Conclusions The Diabeloop CL system is superior to OL devices in reducing hyperglycaemic excursions in patients with T1D exposed to gastronomic dinners, or exposed to physical exercise followed by uncontrolled food and carbohydrate intake.
引用
收藏
页码:324 / 334
页数:11
相关论文
共 42 条
  • [1] Hybrid Closed-Loop Control Is Safe and Effective for People with Type 1 Diabetes Who Are at Moderate to High Risk for Hypoglycemia
    Anderson, Stacey M.
    Buckingham, Bruce A.
    Breton, Marc D.
    Robic, Jessica L.
    Barnett, Charlotte L.
    Wakeman, Christian A.
    Oliveri, Mary C.
    Brown, Sue A.
    Ly, Trang T.
    Clinton, Paula K.
    Hsu, Liana J.
    Kingman, Ryan S.
    Norlander, Lisa M.
    Loebner, Sarah E.
    Reuschel-DiVirglio, Suzette
    Kovatchev, Boris P.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 (06) : 356 - 363
  • [2] Glucose-responsive insulin delivery for type 1 diabetes: The artificial pancreas story
    Bally, Lia
    Thabit, Hood
    Hovorka, Roman
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 544 (02) : 309 - 318
  • [3] Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis
    Bekiari, Eleni
    Kitsios, Konstantinos
    Thabit, Hood
    Tauschmann, Martin
    Athanasiadou, Eleni
    Karagiannis, Thomas
    Haidich, Anna-Bettina
    Hovorka, Roman
    Tsapas, Apostolos
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2018, 361
  • [4] Optimized Mealtime Insulin Dosing for Fat and Protein in Type 1 Diabetes: Application of a Model-Based Approach to Derive Insulin Doses for Open-Loop Diabetes Management
    Bell, Kirstine J.
    Toschi, Elena
    Steil, Garry M.
    Wolpert, Howard A.
    [J]. DIABETES CARE, 2016, 39 (09) : 1631 - 1634
  • [5] Customization of home closed-loop insulin delivery in adult patients with type 1 diabetes, assisted with structured remote monitoring: the pilot WP7 Diabeloop study
    Benhamou, Pierre Yves
    Huneker, Erik
    Franc, Sylvia
    Doron, Maeva
    Charpentier, Guillaume
    [J]. ACTA DIABETOLOGICA, 2018, 55 (06) : 549 - 556
  • [6] Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial
    Benhamou, Pierre-Yves
    Franc, Sylvia
    Reznik, Yves
    Thivolet, Charles
    Schaepelynck, Pauline
    Renard, Eric
    Guerci, Bruno
    Chaillous, Lucy
    Lukas-Croisier, Celine
    Jeandidier, Nathalie
    Hanaire, Helene
    Borot, Sophie
    Doron, Maeva
    Jallon, Pierre
    Xhaard, Ilham
    Melki, Vincent
    Meyer, Laurent
    Delemer, Brigitte
    Guillouche, Marie
    Schoumacker-Ley, Laurene
    Farret, Anne
    Raccah, Denis
    Lablanche, Sandrine
    Joubert, Michael
    Penfornis, Alfred
    Charpentier, Guillaume
    [J]. LANCET DIGITAL HEALTH, 2019, 1 (01): : E17 - E25
  • [7] Automated blood glucose control in type 1 diabetes: A review of progress and challenges
    Bertachi, Arthur
    Ramkissoon, Charrise M.
    Bondia, Jorge
    Vehi, Josep
    [J]. ENDOCRINOLOGIA DIABETES Y NUTRICION, 2018, 65 (03): : 172 - 181
  • [8] DREAM5: An open-label, randomized, cross-over study to evaluate the safety and efficacy of day and night closed-loop control by comparing the MD-Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabetes at home
    Biester, Torben
    Nir, Judith
    Remus, Kerstin
    Farfel, Alon
    Muller, Ido
    Biester, Sarah
    Atlas, Eran
    Dovc, Klemen
    Bratina, Natasa
    Kordonouri, Olga
    Battelino, Tadej
    Philip, Moshe
    Danne, Thomas
    Nimri, Revital
    [J]. DIABETES OBESITY & METABOLISM, 2019, 21 (04) : 822 - 828
  • [10] Closed-Loop Control During Intense Prolonged Outdoor Exercise in Adolescents With Type 1 Diabetes: The Artificial Pancreas Ski Study
    Breton, Marc D.
    Chernavvsky, Daniel R.
    Forlenza, Gregory P.
    DeBoer, Mark D.
    Robic, Jessica
    Wadwa, R. Paul
    Messer, Laurel H.
    Kovatchev, Boris P.
    Maahs, David M.
    [J]. DIABETES CARE, 2017, 40 (12) : 1644 - 1650